Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Driving T-cell immunotherapy to solid tumors

Nature Biotechnology volume 36, pages 215–219 (2018)Cite this article

T cell receptor (TCR) gene therapy can target the immune system to solid tumors in ways CAR-T cells can't match, but the field is still looking for a clear success. Ken Garber reports.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Dueling T-cell receptors.

References

  1. Yanagi, Y. et al. Nature 308, 145–149 (1984).

    Article  CAS  Google Scholar 

  2. Hedrick, S.M., Cohen, D.I., Nielsen, E.A. & Davis, M.M. Nature 308, 149–153 (1984).

    Article  CAS  Google Scholar 

  3. Dembić, Z. et al. Nature 320, 232–238 (1986).

    Article  Google Scholar 

  4. Morgan, R.A. et al. Science 314, 126–129 (2006).

    Article  CAS  Google Scholar 

  5. Holler, P.D. et al. Proc. Natl. Acad. Sci. USA 97, 5387–5392 (2000).

    Article  CAS  Google Scholar 

  6. Robbins, P.F. et al. J. Clin. Oncol. 29, 917–924 (2011).

    Article  Google Scholar 

  7. Parkhurst, M.R. et al. Mol. Ther. 19, 620–626 (2011).

    Article  CAS  Google Scholar 

  8. Morgan, R.A. et al. J. Immunother. 36, 133–151 (2013).

    Article  CAS  Google Scholar 

  9. Linette, G.P. et al. Blood 122, 863–871 (2013).

    Article  CAS  Google Scholar 

  10. Schmitt, T.M. et al. Blood 122, 348–356 (2013).

    Article  CAS  Google Scholar 

  11. Mackall, C. et al. J. Clin. Oncol. 35, suppl; abstr. 3000 (2017).

    Article  Google Scholar 

  12. Lu, Y.C. et al. Clin. Cancer Res. 20, 3401–3410 (2014).

    Article  CAS  Google Scholar 

  13. Tran, E. et al. Science 344, 641–645 (2014).

    Article  CAS  Google Scholar 

  14. Deniger, D.C. et al. Mol. Ther. 24, 1078–1089 (2016).

    Article  CAS  Google Scholar 

  15. Oda, S.K. et al. Blood 130, 2410–2419 (2017).

    Article  CAS  Google Scholar 

  16. Corrales, L., McWhirter, S.M., Dubensky, T.W. Jr. & Gajewski, T.F. J. Clin. Invest. 126, 2404–2411 (2016).

    Article  Google Scholar 

  17. Roybal, K.T. et al. Cell 164, 770–779 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ann Arbor, Michigan

    Ken Garber

Authors
  1. Ken Garber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garber, K. Driving T-cell immunotherapy to solid tumors. Nat Biotechnol 36, 215–219 (2018). https://doi.org/10.1038/nbt.4090

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.4090

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing